linked in

26 November 2007

ISPE, a global not-for-profit association of 25,000 pharmaceutical manufacturing professionals, announced Russ Somma, Ph.D., as the winner of the Max Seales Yonker Member of the Year...

For more information contact:
Marsha Strickhouser
Public Relations Manager
Tel: +1-813-960-2105, ext. 277
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
www.ispe.org   

ISPE Awards Russ Somma, Ph.D. Max Seales Yonker Member of the Year 

TAMPA, FLORIDA, USA, 26 November 2007

ISPE, a global not-for-profit association of 25,000 pharmaceutical manufacturing professionals, announced Russ Somma, Ph.D., as the winner of the Max Seales Yonker Member of the Year. Robert P. Best, President and Chief Executive Officer of ISPE, presented the honors on 6 November at the Society’s 2007 Annual Meeting in Las Vegas, Nevada, USA. The award honors the ISPE Member who has made the most significant contribution to the Society during the past year. It is named in honor of a dynamic lady who contributed to the Society in many ways and served as a source of inspiration during her battle with cancer.

“Russ’s leadership has enabled the Society to develop the new credential – the Certified Pharmaceutical Industry Professional (CPIP SM), the first competency-based international certification for pharmaceutical professionals covering a range of competencies from drug product development through manufacturing,” said Robert P. Best. “Russ is a major contributor to ISPE initiatives and is dedicated to raising the bar on product quality and manufacturing efficiency throughout the industry. In 1997, he chaired and launched another important ISPE initiative, ISPE’s Scale Up & Post Approval Changes (SUPAC) Equipment Guidance, the successful partnership with the Food and Drug Administration (FDA) that received US Vice Presidential commendation. Russ also took the lead in organizing Product Quality Lifecycle Implementation or PQLI,” said Best. “Thanks to his vision and technical leadership, industry, regulatory authorities, and the global public are likely to benefit for years to come.”

As president of SommaTech, an affiliate company of IPS, his focus is on pharmaceutical technology and helping clients achieve FDA regulated product goals for fast submission, seamless approval, cost effective product, and a secure supply chain. Throughout his career, Dr. Somma has been involved in production support, scale-up, pilot plants, as well as early and full development activities of pharmaceutical products, which include novel as well as traditional dosage forms. He has provided support for 21 NDAs in the chemistry, manufacturing and control area, from submission through the pre-approval inspection phase. Dr. Somma earned his Ph.D. in pharmaceutical science under N.G. Lordi at Rutgers University College of Pharmacy. He earned a Masters degree in pharmaceutical science and a Bachelors degree in pharmacy also from Rutgers University.



About ISPE ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical manufacturing professionals in 90 countries around the globe. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; and its Asia Pacific office in Singapore. Visit www.ISPE.org for additional Society news and information.